Detalhe da pesquisa
1.
Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria.
N Engl J Med;
390(11): 994-1008, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38477987
2.
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT.
Blood;
2024 Apr 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38643511
3.
Discovering C3 targeting therapies for paroxysmal nocturnal hemoglobinuria: Achievements and pitfalls.
Semin Immunol;
59: 101618, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35764467
4.
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.
N Engl J Med;
386(1): 11-23, 2022 01 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34986284
5.
Rare germline complement factor H variants in patients with paroxysmal nocturnal hemoglobinuria.
Blood;
141(15): 1812-1816, 2023 04 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36626252
6.
The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia.
Blood;
141(23): 2853-2866, 2023 06 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36952636
7.
Immune landscape after allo-HSCT: TIGIT- and CD161-expressing CD4 T cells are associated with subsequent leukemia relapse.
Blood;
140(11): 1305-1321, 2022 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35820057
8.
Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation.
Blood;
140(23): 2500-2513, 2022 12 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35984904
9.
Real-world experience of pegcetacoplan in paroxysmal nocturnal hemoglobinuria.
Am J Hematol;
99(5): 816-823, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38348608
10.
Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT.
Am J Hematol;
99(5): 993-996, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38385579
11.
Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case-control study in the International PNH Registry.
Ann Hematol;
102(11): 2979-2988, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37668788
12.
Systemic complement activation influences outcomes after allogeneic hematopoietic cell transplantation: A prospective French multicenter trial.
Am J Hematol;
98(10): 1559-1570, 2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37483161
13.
Clinical and immune features of human parvovirus B19 infection in allogeneic stem cell transplantation recipients: A retrospective monocentric study.
Transpl Infect Dis;
25(5): e14118, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37594199
14.
How we('ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future.
Br J Haematol;
196(2): 288-303, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34355382
15.
The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria.
Blood;
135(12): 912-920, 2020 03 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31978221
16.
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors.
Haematologica;
107(5): 1045-1053, 2022 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34382386
17.
Emerging drugs for the treatment of paroxysmal nocturnal hemoglobinuria.
Expert Opin Emerg Drugs;
27(1): 33-43, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35078384
18.
Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies.
Eur J Haematol;
109(3): 205-214, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35502600
19.
Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study.
Br J Haematol;
193(4): 814-826, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33844842
20.
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study.
Blood;
133(6): 540-549, 2019 02 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30510079